Anders Hartmann
Position: Professor II
Phone: +47-23071936
Email:
 

Publications 2017

Dahle DO, Grotmol T, Leivestad T, Hartmann A, Midtvedt K, Reisæter AV, Mjøen G, Pihlstrøm HK, Næss H, Holdaas H (2017)
Association Between Pretransplant Cancer and Survival in Kidney Transplant Recipients
Transplantation (in press)
PubMed 28207636

Egeland EJ, Robertsen I, Hermann M, Midtvedt K, Størset E, Gustavsen MT, Reisæter AV, Klaasen R, Bergan S, Holdaas H, Hartmann A, Åsberg A (2017)
High tacrolimus clearance is a risk factor for acute rejection in the early phase after renal transplantation
Transplantation (in press)
PubMed 28452920

Eide IA, Halden TAS, Hartmann A, Dahle DO, Åsberg A, Jenssen T (2017)
Associations Between Posttransplantation Diabetes Mellitus and Renal Graft Survival
Transplantation, 101 (6), 1282-1289
PubMed 27362306

Heldal K, Hartmann A, Lønning K, Leivestad T, Reisæter AV, Line PD, Holdaas H, Midtvedt K (2017)
Should patients older than 65 years be offered a second kidney transplant?
BMC Nephrol, 18 (1), 13
PubMed 28077080

Jenssen T, Hartmann A, Birkeland KI (2017)
Long-term diabetes complications after pancreas transplantation
Curr Opin Organ Transplant (in press)
PubMed 28598888

Lindahl JP, Massey RJ, Hartmann A, Aakhus S, Endresen K, Günther A, Midtvedt K, Holdaas H, Leivestad T, Horneland R, Øyen O, Jenssen T (2017)
Cardiac Assessment of Patients With Type 1 Diabetes Median 10 Years After Successful Simultaneous Pancreas and Kidney Transplantation Compared With Living Donor Kidney Transplantation
Transplantation, 101 (6), 1261-1267
PubMed 27467687

Meyer KB, Hartmann A, Mjøen G, Andersen MH (2017)
Relationships Between Clinical, Self-Reported, and Donation Specific Outcomes: A Prospective Follow-up Study 10 Years After Kidney Donation
Ann Transplant, 22, 148-155
PubMed 28321111

Pihlstrøm HK, Gatti F, Hammarström C, Eide IA, Kasprzycka M, Wang J, Haraldsen G, Svensson MHS, Midtvedt K, Mjøen G, Dahle DO, Hartmann A, Holdaas H (2017)
Early introduction of oral paricalcitol in renal transplant recipients. An open-label randomized study
Transpl Int (in press)
PubMed 28436117

Rose J, Emery VC, Kumar D, Asberg A, Hartmann A, Jardine AG, Bignamini AA, Humar A, Neumann AU (2017)
Correction: Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection
PLoS Pathog, 13 (5), e1006386
PubMed 28489893

Rose J, Emery VC, Kumar D, Asberg A, Hartmann A, Jardine AG, Bignamini AA, Humar A, Neumann AU (2017)
Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection
PLoS Pathog, 13 (4), e1006299
PubMed 28406982

Publications 2016

Dörje C, Reisaeter AV, Dahle DO, Mjøen G, Midtvedt K, Holdaas H, Flaa-Johnsen L, Syversveen T, Hartmann A, Jenssen T, Scott H, Reinholt FP (2016)
Total inflammation in early protocol kidney graft biopsies does not predict progression of fibrosis at one year post-transplant
Clin Transplant, 30 (7), 802-9
PubMed 27101801

Eide IA, Halden TA, Hartmann A, Åsberg A, Dahle DO, Reisaeter AV, Jenssen T (2016)
Mortality risk in post-transplantation diabetes mellitus based on glucose and HbA1c diagnostic criteria
Transpl Int, 29 (5), 568-78
PubMed 26875590

Eide IA, Åsberg A, Svensson M, Ueland T, Mollnes TE, Hartmann A, Bjerve KS, Michelsen A, Aukrust P, Christensen JH, Schmidt EB, Jenssen T (2016)
Plasma Levels of Marine n-3 Fatty Acids Are Inversely Correlated With Proinflammatory Markers sTNFR1 and IL-6 in Renal Transplant Recipients
J Ren Nutr, 27 (3), 161-168
PubMed 27838193

Halden TA, Egeland EJ, Åsberg A, Hartmann A, Midtvedt K, Khiabani HZ, Holst JJ, Knop FK, Hornum M, Feldt-Rasmussen B, Jenssen T (2016)
GLP-1 Restores Altered Insulin and Glucagon Secretion in Posttransplantation Diabetes
Diabetes Care, 39 (4), 617-24
PubMed 26908914

Jørgensen HS, Eide IA, Hartmann A, Åsberg A, Christensen JH, Schmidt EB, Godang K, Bollerslev J, Svensson M (2016)
Plasma n-3 Polyunsaturated Fatty Acids and Bone Mineral Density in Renal Transplant Recipients
J Ren Nutr, 26 (3), 196-203
PubMed 26776249

Lønning K, Midtvedt K, Leivestad T, Reisæter AV, Line PD, Hartmann A, Heldal K (2016)
Are Octogenarians With End-Stage Renal Disease Candidates for Renal Transplantation?
Transplantation, 100 (12), 2705-2709
PubMed 27861296

Meyer K, Wahl AK, Bjørk IT, Wisløff T, Hartmann A, Andersen MH (2016)
Long-term, self-reported health outcomes in kidney donors
BMC Nephrol, 17, 8
PubMed 26754798

Mjøen G, Reisaeter A, Hallan S, Line PD, Hartmann A, Midtvedt K, Foss A, Dahle DO, Holdaas H (2016)
Overall and cardiovascular mortality in Norwegian kidney donors compared to the background population
Nephrol Dial Transplant, 31 (1), 170
PubMed 26740671

Nordheim E, Dahle DO, Syse IM, Åsberg A, Reisæter AV, Hartmann A (2016)
Resolution of Calciphylaxis After Urgent Kidney Transplantation in 3 Patients With End-Stage Kidney Failure
Transplant Direct, 2 (11), e113
PubMed 27826606

Smedbråten J, Mjøen G, Hartmann A, Åsberg A, Rollag H, Mollnes TE, Sandvik L, Fagerland MW, Thiel S, Sagedal S (2016)
Low level of MAp44, an inhibitor of the lectin complement pathway, and long-term graft and patient survival; a cohort study of 382 kidney recipients
BMC Nephrol, 17 (1), 148
PubMed 27760523

Størset E, Åsberg A, Hartmann A, Reisaeter AV, Holdaas H, Skauby M, Bergan S, Midtvedt K (2016)
Low-target tacrolimus in de novo standard risk renal transplant recipients: A single-centre experience
Nephrology (Carlton), 21 (10), 821-7
PubMed 26854648

von Düring ME, Jenssen T, Bollerslev J, Åsberg A, Godang K, Hartmann A (2016)
Visceral fat is strongly associated with post-transplant diabetes mellitus and glucose metabolism 1 year after kidney transplantation
Clin Transplant, 31 (1)
PubMed 27859633

Åsberg A, Humar A, Rollag H, Jardine AG, Kumar D, Aukrust P, Ueland T, Bignamini AA, Hartmann A (2016)
Lessons Learned From a Randomized Study of Oral Valganciclovir Versus Parenteral Ganciclovir Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients: The VICTOR Trial
Clin Infect Dis, 62 (9), 1154-60
PubMed 26908810

Publications 2015

Dahle DO, Eide IA, Åsberg A, Leivestad T, Holdaas H, Jenssen TG, Fagerland MW, Pihlstrøm H, Mjøen G, Hartmann A (2015)
Aortic Stiffness in a Mortality Risk Calculator for Kidney Transplant Recipients
Transplantation, 99 (8), 1730-7
PubMed 25757216

Eide IA, Halden TA, Hartmann A, Åsberg A, Dahle DO, Reisæter AV, Jenssen T (2015)
Limitations of hemoglobin A1c for the diagnosis of posttransplant diabetes mellitus
Transplantation, 99 (3), 629-35
PubMed 25162478

Eide IA, Jenssen T, Hartmann A, Diep LM, Dahle DO, Reisæter AV, Bjerve KS, Christensen JH, Schmidt EB, Svensson M (2015)
The association between marine n-3 polyunsaturated fatty acid levels and survival after renal transplantation
Clin J Am Soc Nephrol, 10 (7), 1246-56
PubMed 26063768

Eide IA, Jenssen T, Hartmann A, Diep LM, Dahle DO, Reisæter AV, Bjerve KS, Christensen JH, Schmidt EB, Svensson M (2015)
Plasma levels of marine n-3 polyunsaturated fatty acids and renal allograft survival
Nephrol Dial Transplant, 31 (1), 160-7
PubMed 26410884

Jenssen T, Hartmann A (2015)
Emerging treatments for post-transplantation diabetes mellitus
Nat Rev Nephrol, 11 (8), 465-77
PubMed 25917553

Lindahl JP, Hartmann A, Aakhus S, Endresen K, Midtvedt K, Holdaas H, Leivestad T, Horneland R, Øyen O, Jenssen T (2015)
Long-term cardiovascular outcomes in type 1 diabetic patients after simultaneous pancreas and kidney transplantation compared with living donor kidney transplantation
Diabetologia, 59 (4), 844-52
PubMed 26713324

Smedbråten YV, Sagedal S, Mjøen G, Hartmann A, Fagerland MW, Rollag H, Mollnes TE, Thiel S (2015)
High ficolin-3 level at the time of transplantation is an independent risk factor for graft loss in kidney transplant recipients
Transplantation, 99 (4), 791-6
PubMed 25222012

Ueland T, Rollag H, Hartmann A, Jardine A, Humar A, Bignamini AA, Åsberg A, Aukrust P (2015)
Increased osteoprotegerin predicts poor virological outcome during anticytomegalovirus therapy in solid organ transplant recipients
Transplantation, 99 (1), 100-5
PubMed 24983306

von Düring ME, Jenssen T, Bollerslev J, Åsberg A, Godang K, Eide IA, Dahle DO, Hartmann A (2015)
Visceral fat is better related to impaired glucose metabolism than body mass index after kidney transplantation
Transpl Int, 28 (10), 1162-71
PubMed 25970153

Publications 2014

Aulie HA, Selvaag AM, Günther A, Lilleby V, Molberg Ø, Hartmann A, Holdaas H, Flatø B (2014)
Arterial haemodynamics and coronary artery calcification in adult patients with juvenile idiopathic arthritis
Ann Rheum Dis, 74 (8), 1515-21
PubMed 24695010

Bleskestad IH, Bergrem H, Leivestad T, Hartmann A, Gøransson LG (2014)
Parathyroid hormone and clinical outcome in kidney transplant patients with optimal transplant function
Clin Transplant, 28 (4), 479-86
PubMed 25649861

Chen Z, Bouamar R, Van Schaik RH, De Fijter JW, Hartmann A, Zeier M, Budde K, Kuypers DR, Weimar W, Hesselink DA, Van Gelder T (2014)
Genetic polymorphisms in IL-2, IL-10, TGF-β1, and IL-2RB and acute rejection in renal transplant patients
Clin Transplant, 28 (6), 649-55
PubMed 24579958

Dahle DO, Jenssen T, Holdaas H, Asberg A, Soveri I, Holme I, Mjøen G, Eide IA, Pihlstrøm H, Dörje C, Halden TA, Hartmann A (2014)
Uric acid and clinical correlates of endothelial function in kidney transplant recipients
Clin Transplant, 28 (10), 1167-76
PubMed 25124959

Lindahl JP, Jenssen T, Hartmann A (2014)
Long-term outcomes after organ transplantation in diabetic end-stage renal disease
Diabetes Res Clin Pract, 105 (1), 14-21
PubMed 24698407

Lindahl JP, Reinholt FP, Eide IA, Hartmann A, Midtvedt K, Holdaas H, Dorg LT, Reine TM, Kolset SO, Horneland R, Øyen O, Brabrand K, Jenssen T (2014)
In patients with type 1 diabetes simultaneous pancreas and kidney transplantation preserves long-term kidney graft ultrastructure and function better than transplantation of kidney alone
Diabetologia, 57 (11), 2357-65
PubMed 25145544

Reine TM, Kolseth IB, Meen AJ, Lindahl JP, Jenssen TG, Reinholt FP, Zaia J, Shao C, Hartmann A, Kolset SO (2014)
Effects of restoring normoglycemia in type 1 diabetes on inflammatory profile and renal extracellular matrix structure after simultaneous pancreas and kidney transplantation
Diabetes Res Clin Pract, 107 (1), 46-53
PubMed 25467621

Strøm Halden TA, Åsberg A, Vik K, Hartmann A, Jenssen T (2014)
Short-term efficacy and safety of sitagliptin treatment in long-term stable renal recipients with new-onset diabetes after transplantation
Nephrol Dial Transplant, 29 (4), 926-33
PubMed 24452849

Publications 2013

Dahle DO, Jenssen T, Holdaas H, Leivestad T, Vårdal M, Mjøen G, Reisaeter AV, Toft I, Hartmann A (2013)
Uric acid has a J-shaped association with cardiovascular and all-cause mortality in kidney transplant recipients
Clin Transplant, 28 (1), 134-40
PubMed 24372653

Dahle DO, Midtvedt K, Hartmann A, Jenssen T, Holdaas H, Mjøen G, Leivestad T, Asberg A (2013)
Endothelial dysfunction is associated with graft loss in renal transplant recipients
Transplantation, 95 (5), 733-9
PubMed 23364481

Dörje C, Midtvedt K, Holdaas H, Naper C, Strøm EH, Øyen O, Leivestad T, Aronsen T, Jenssen T, Flaa-Johnsen L, Lindahl JP, Hartmann A, Reisæter AV (2013)
Early versus late acute antibody-mediated rejection in renal transplant recipients
Transplantation, 96 (1), 79-84
PubMed 23632391

Flechner SM, Gurkan A, Hartmann A, Legendre CM, Russ GR, Campistol JM, Schena FP, Hahn CM, Li H, Korth-Bradley JM, Tai SS, Schulman SL (2013)
A randomized, open-label study of sirolimus versus cyclosporine in primary de novo renal allograft recipients
Transplantation, 95 (10), 1233-41
PubMed 23689085

Heldal K, Thorarinsdottir S, Hartmann A, Leivestad T, Reisæter AV, Foss AE, Midtvedt K (2013)
Induction with interleukin-2 antagonist for transplantation of kidneys from older deceased donors: an observational study
Transplant Res, 2 (1), 11
PubMed 23799993

Mjøen G, Hallan S, Hartmann A, Foss A, Midtvedt K, Øyen O, Reisæter A, Pfeffer P, Jenssen T, Leivestad T, Line PD, Øvrehus M, Dale DO, Pihlstrøm H, Holme I, Dekker FW, Holdaas H (2013)
Long-term risks for kidney donors
Kidney Int, 86 (1), 162-7
PubMed 24284516

Rollag H, Ueland T, Asberg A, Hartmann A, Jardine AG, Humar A, Pescovitz MD, Bignamini AA, Aukrust P (2013)
Characterization of cytomegalovirus disease in solid organ transplant recipients by markers of inflammation in plasma
PLoS One, 8 (4), e60767
PubMed 23593305

Smedbråten YV, Sagedal S, Leivestad T, Mjøen G, Osnes K, Rollag H, Reisaeter AV, Foss A, Os I, Hartmann A (2013)
The impact of early cytomegalovirus infection after kidney transplantation on long-term graft and patient survival
Clin Transplant, 28 (1), 120-6
PubMed 24351078

Åsberg A, Apeland T, Reisaeter AV, Foss A, Leivestad T, Heldal K, Thorud LO, Eriksen BO, Hartmann A, NILS Study Group (2013)
Long-term outcomes after cyclosporine or mycophenolate withdrawal in kidney transplantation - results from an aborted trial
Clin Transplant, 27 (2), E151-6
PubMed 23351013

Åsberg A, Midtvedt K, van Guilder M, Størset E, Bremer S, Bergan S, Jelliffe R, Hartmann A, Neely MN (2013)
Inclusion of CYP3A5 genotyping in a nonparametric population model improves dosing of tacrolimus early after transplantation
Transpl Int, 26 (12), 1198-207
PubMed 24118301

Publications 2012

Bleskestad IH, Bergrem H, Hartmann A, Godang K, Gøransson LG (2012)
Fibroblast growth factor 23 and parathyroid hormone after treatment with active vitamin D and sevelamer carbonate in patients with chronic kidney disease stage 3b, a randomized crossover trial
BMC Nephrol, 13, 49
PubMed 22742720

Emery VC, Manuel O, Asberg A, Pang X, Kumar D, Hartmann A, Preiksaitis JK, Pescovitz MD, Rollag H, Jardine AG, Gahlemann CG, Humar A (2012)
Differential decay kinetics of human cytomegalovirus glycoprotein B genotypes following antiviral chemotherapy
J Clin Virol, 54 (1), 56-60
PubMed 22410132

Hartmann A, Jenssen T, Holdaas H (2012)
Diabetes, chronic kidney disease and cancer risk
Nephrol Dial Transplant, 27 (8), 3018-20
PubMed 22734106

Holme I, Fellström BC, Jardine AG, Hartmann A, Holdaas H (2012)
Model comparisons of competing risk and recurrent events for graft failure in renal transplant recipients
Clin J Am Soc Nephrol, 8 (2), 241-7
PubMed 23160259

Loftheim H, Midtvedt K, Hartmann A, Reisæter AV, Falck P, Holdaas H, Jenssen T, Reubsaet L, Asberg A (2012)
Urinary proteomic shotgun approach for identification of potential acute rejection biomarkers in renal transplant recipients
Transplant Res, 1 (1), 9
PubMed 23369437

Rollag H, Asberg A, Ueland T, Hartmann A, Jardine AG, Humar A, Pescovitz MD, Bignamini AA, Aukrust P (2012)
Treatment of cytomegalovirus disease in solid organ transplant recipients: markers of inflammation as predictors of outcome
Transplantation, 94 (10), 1060-5
PubMed 23104251

Valderhaug TG, Hjelmesæth J, Jenssen T, Røislien J, Leivestad T, Hartmann A (2012)
Early posttransplantation hyperglycemia in kidney transplant recipients is associated with overall long-term graft losses
Transplantation, 94 (7), 714-20
PubMed 22965263

Publications 2011

Bjørneklett R, Vikse BE, Smerud HK, Bostad L, Leivestad T, Hartmann A, Iversen BM (2011)
Pre-transplant course and risk of kidney transplant failure in IgA nephropathy patients
Clin Transplant, 25 (3), E356-65
PubMed 21651619

Heldal K, Hartmann A, Leivestad T, Foss A, Midtvedt K (2011)
Risk variables associated with the outcome of kidney recipients >70 years of age in the new millennium
Nephrol Dial Transplant, 26 (8), 2706-11
PubMed 21285131

Heldal K, Hartmann A, Leivestad T, Lien B, Foss AE, Midtvedt K (2011)
Renal transplantation is also an option for patients over 70
Tidsskr Nor Laegeforen, 131 (20), 2004-7
PubMed 22016126

Jenssen T, Hartmann A (2011)
Prevention and management of transplant-associated diabetes
Expert Opin Pharmacother, 12 (17), 2641-55
PubMed 22047007

Lisboa LF, Asberg A, Kumar D, Pang X, Hartmann A, Preiksaitis JK, Pescovitz MD, Rollag H, Jardine AG, Humar A (2011)
The clinical utility of whole blood versus plasma cytomegalovirus viral load assays for monitoring therapeutic response
Transplantation, 91 (2), 231-6
PubMed 21048530

Midtvedt K, Jenssen T, Hartmann A, Vethe NT, Bergan S, Havnes K, Åsberg A (2011)
No change in insulin sensitivity in renal transplant recipients converted from standard to once-daily prolonged release tacrolimus
Nephrol Dial Transplant, 26 (11), 3767-72
PubMed 21471328

Mjøen G, Reisaeter A, Hallan S, Line PD, Hartmann A, Midtvedt K, Foss A, Dahle DO, Holdaas H (2011)
Overall and cardiovascular mortality in Norwegian kidney donors compared to the background population
Nephrol Dial Transplant, 27 (1), 443-7
PubMed 21636826

Myhre HA, Haug Dorenberg D, Kristiansen KI, Rollag H, Leivestad T, Asberg A, Hartmann A (2011)
Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients
Transplantation, 92 (2), 217-23
PubMed 21685829

Norby GE, Günther A, Mjøen G, Andersen R, Dolgos S, Hartmann A, Holdaas H (2011)
Prevalence and risk factors for coronary artery calcification following kidney transplantation for systemic lupus erythematosus
Rheumatology (Oxford), 50 (9), 1659-64
PubMed 21624893

Norby GE, Leivestad T, Mjøen G, Hartmann A, Midtvedt K, Gran JT, Holdaas H (2011)
Premature cardiovascular disease in patients with systemic lupus erythematosus influences survival after renal transplantation
Arthritis Rheum, 63 (3), 733-7
PubMed 21360503

Reisaeter AV, Foss A, Hartmann A, Leivestad T, Midtvedt K (2011)
The kidney transplantation program in Norway since 2000
Clin Transpl, 111-8
PubMed 22755407

Sagedal S, Witczak BJ, Osnes K, Hartmann A, Os I, Eikvar L, Klingenberg O, Brosstad F (2011)
A heparin-coated dialysis filter (AN69 ST) does not reduce clotting during hemodialysis when compared to a conventional polysulfone filter (F×8)
Blood Purif, 32 (3), 151-5
PubMed 21659742

Syversveen T, Brabrand K, Midtvedt K, Strøm EH, Hartmann A, Berstad AE (2011)
Non-invasive assessment of renal allograft fibrosis by dynamic sonographic tissue perfusion measurement
Acta Radiol, 52 (8), 920-6
PubMed 21873503

Publications 2010

Asberg A, Falck P, Undset LH, Dørje C, Holdaas H, Hartmann A, Midtvedt K (2010)
Computer-assisted cyclosporine dosing performs better than traditional dosing in renal transplant recipients: results of a pilot study
Ther Drug Monit, 32 (2), 152-8
PubMed 20216113

Asberg A, Jardine AG, Bignamini AA, Rollag H, Pescovitz MD, Gahlemann CC, Humar A, Hartmann A, VICTOR Study Group (2010)
Effects of the intensity of immunosuppressive therapy on outcome of treatment for CMV disease in organ transplant recipients
Am J Transplant, 10 (8), 1881-8
PubMed 20486914

Asberg A, Rollag H, Hartmann A (2010)
Valganciclovir for the prevention and treatment of CMV in solid organ transplant recipients
Expert Opin Pharmacother, 11 (7), 1159-66
PubMed 20367273

Bergrem HA, Valderhaug TG, Hartmann A, Hjelmesaeth J, Leivestad T, Bergrem H, Jenssen T (2010)
Undiagnosed diabetes in kidney transplant candidates: a case-finding strategy
Clin J Am Soc Nephrol, 5 (4), 616-22
PubMed 20133490

Dolgos S, Hartmann A, Isaksen GA, Simonsen S, Bjørtuft Ø, Boberg KM, Bollerslev J (2010)
Osteoporosis is a prevalent finding in patients with solid organ failure awaiting transplantation - a population based study
Clin Transplant, 24 (5), E145-52
PubMed 20236290

Elgstoen KB, Johnsen LF, Woldseth B, Morkrid L, Hartmann A (2010)
Plasma oxalate following kidney transplantation in patients without primary hyperoxaluria
Nephrol Dial Transplant, 25 (7), 2341-5
PubMed 20167571

Gude E, Andreassen AK, Arora S, Gullestad L, Grov I, Hartmann A, Leivestad T, Fiane AE, Geiran OR, Vardal M, Simonsen S (2010)
Acute renal failure early after heart transplantation: risk factors and clinical consequences
Clin Transplant, 24 (6), E207-13
PubMed 20184627

Gude E, Gullestad L, Arora S, Simonsen S, Hoel I, Hartmann A, Holdaas H, Fiane AE, Geiran OR, Andreassen AK (2010)
Benefit of early conversion from CNI-based to everolimus-based immunosuppression in heart transplantation
J Heart Lung Transplant, 29 (6), 641-7
PubMed 20304681

Hirsch HH, Hartmann A (2010)
Immunotherapy for invasive fungal infections in transplant patients: back to the future?
Am J Transplant, 10 (8), 1719-20
PubMed 20636453

Hjelmesæth J, Røislien J, Nordstrand N, Hofsø D, Hager H, Hartmann A (2010)
Low serum creatinine is associated with type 2 diabetes in morbidly obese women and men: a cross-sectional study
BMC Endocr Disord, 10, 6
PubMed 20398422

Norby GE, Lerang K, Holdaas H, Gran JT, Strøm EH, Draganov B, Os I, Hartmann A, Gilboe IM (2010)
[Lupus-nephritis--diagnosis and treatment]
Tidsskr Nor Laegeforen, 130 (11), 1140-4
PubMed 20531500

Norby GE, Strøm EH, Midtvedt K, Hartmann A, Gilboe IM, Leivestad T, Stenstrøm J, Holdaas H (2010)
Recurrent lupus nephritis after kidney transplantation: a surveillance biopsy study
Ann Rheum Dis, 69 (8), 1484-7
PubMed 20498208

Syversveen T, Brabrand K, Midtvedt K, Strøm EH, Hartmann A, Jakobsen JA, Berstad AE (2010)
Assessment of renal allograft fibrosis by acoustic radiation force impulse quantification--a pilot study
Transpl Int, 24 (1), 100-5
PubMed 20819192

Publications 2009

Amundsen R, Asberg A, Robertsen I, Vethe NT, Bergan S, Hartmann A, Midtvedt K (2009)
Rimonabant affects cyclosporine a, but not tacrolimus pharmacokinetics in renal transplant recipients
Transplantation, 87 (8), 1221-4
PubMed 19384170

Asberg A, Midtvedt K, Voytovich MH, Line PD, Narverud J, Reisaeter AV, Mørkrid L, Jenssen T, Hartmann A (2009)
Calcineurin inhibitor effects on glucose metabolism and endothelial function following renal transplantation
Clin Transplant, 23 (4), 511-8
PubMed 19210527

Bergrem HA, Valderhaug TG, Hartmann A, Bergrem H, Hjelmesaeth J, Jenssen T (2009)
Glucose tolerance before and after renal transplantation
Nephrol Dial Transplant, 25 (3), 985-92
PubMed 19854851

Boivin G, Goyette N, Rollag H, Jardine AG, Pescovitz MD, Asberg A, Ives J, Hartmann A, Humar A (2009)
Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir
Antivir Ther, 14 (5), 697-704
PubMed 19704173

Dolgos S, Hartmann A, Bønsnes S, Isaksen GA, Godang K, Ueland T, Pfeffer P, Bollerslev J (2009)
Early changes in bone mass, biochemical bone markers and fibroblast growth factor 23 after renal transplantation
Scand J Clin Lab Invest, 69 (2), 161-7
PubMed 18972258

Dolgos S, Hartmann A, Jenssen T, Isaksen GA, Pfeffer P, Bollerslev J (2009)
Determinants of short-term changes in body composition following renal transplantation
Scand J Urol Nephrol, 43 (1), 76-83
PubMed 18777442

Falck P, Midtvedt K, Vân Lê TT, Storehagen L, Holdaas H, Hartmann A, Asberg A (2009)
A population pharmacokinetic model of ciclosporin applicable for assisting dose management of kidney transplant recipients
Clin Pharmacokinet, 48 (9), 615-23
PubMed 19725595

Heldal K, Hartmann A, Grootendorst DC, de Jager DJ, Leivestad T, Foss A, Midtvedt K (2009)
Benefit of kidney transplantation beyond 70 years of age
Nephrol Dial Transplant, 25 (5), 1680-7
PubMed 20038521

Heldal K, Hartmann A, Leivestad T, Svendsen MV, Foss A, Lien B, Midtvedt K (2009)
Clinical outcomes in elderly kidney transplant recipients are related to acute rejection episodes rather than pretransplant comorbidity
Transplantation, 87 (7), 1045-51
PubMed 19352126

Manuel O, Asberg A, Pang X, Rollag H, Emery VC, Preiksaitis JK, Kumar D, Pescovitz MD, Bignamini AA, Hartmann A, Jardine AG, Humar A (2009)
Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease
Clin Infect Dis, 49 (8), 1160-6
PubMed 19751151

Valderhaug TG, Jenssen T, Hartmann A, Midtvedt K, Holdaas H, Reisaeter AV, Hjelmesaeth J (2009)
Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation
Transplantation, 88 (3), 429-34
PubMed 19667949

Witczak BJ, Leivestad T, Line PD, Holdaas H, Reisaeter AV, Jenssen TG, Midtvedt K, Bitter J, Hartmann A (2009)
Experience from an active preemptive kidney transplantation program--809 cases revisited
Transplantation, 88 (5), 672-7
PubMed 19741464

Aasebø W, Hartmann A, Jenssen T (2009)
Predictors of anemia in patients on hemodialysis
Hemodial Int, 13 (3), 335-9
PubMed 19614760

Aasebø W, Midtvedt K, Valderhaug TG, Leivestad T, Hartmann A, Reisaeter AV, Jenssen T, Holdaas H (2009)
Impaired glucose homeostasis in renal transplant recipients receiving basiliximab
Nephrol Dial Transplant, 25 (4), 1289-93
PubMed 19934089

Publications 2008

Apeland T, Hartmann A (2008)
Rituximab therapy in early recurrent focal segmental sclerosis after renal transplantation
Nephrol Dial Transplant, 23 (6), 2091-4
PubMed 18319357

Bergrem HA, Bergrem H, Hartmann A, Hjelmesaeth J, Jenssen T (2008)
Role of prednisolone pharmacokinetics in postchallenge glycemia after renal transplantation
Ther Drug Monit, 30 (5), 583-90
PubMed 18728625

Dolgos S, Hartmann A, Bønsnes S, Ueland T, Isaksen GA, Godang K, Pfeffer P, Bollerslev J (2008)
Determinants of bone mass in end-stage renal failure patients at the time of kidney transplantation
Clin Transplant, 22 (4), 462-8
PubMed 18318737

Falck P, Asberg A, Guldseth H, Bremer S, Akhlaghi F, Reubsaet JL, Pfeffer P, Hartmann A, Midtvedt K (2008)
Declining intracellular T-lymphocyte concentration of cyclosporine a precedes acute rejection in kidney transplant recipients
Transplantation, 85 (2), 179-84
PubMed 18212621

Foss A, Gunther A, Line PD, Brabrand K, Holdaas H, Hartmann A, Midtvedt K (2008)
Long-term clinical outcome of paediatric kidneys transplanted to adults
Nephrol Dial Transplant, 23 (2), 726-9
PubMed 18198285

Gunther A, Foss A, Holdaas H, Brabrand K, Hartmann A, Line PD, Midtvedt K (2008)
Increased peak systolic velocity in the renal artery of paediatric kidneys transplanted to adult recipients
Nephrol Dial Transplant, 23 (12), 4041-3
PubMed 18586763

Hesselink DA, van Schaik RH, van Agteren M, de Fijter JW, Hartmann A, Zeier M, Budde K, Kuypers DR, Pisarski P, Le Meur Y, Mamelok RD, van Gelder T (2008)
CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients
Pharmacogenet Genomics, 18 (4), 339-48
PubMed 18334918

Humar A, Asberg A, Kumar D, Hartmann A, Moussa G, Jardine A, Rollag H, Mouas H, Gahlemann CG, Pescovitz MD, VICTOR study group (2008)
An assessment of herpesvirus co-infections in patients with CMV disease: correlation with clinical and virologic outcomes
Am J Transplant, 9 (2), 374-81
PubMed 19120074

Sagedal S, Thiel S, Hansen TK, Mollnes TE, Rollag H, Hartmann A (2008)
Impact of the complement lectin pathway on cytomegalovirus disease early after kidney transplantation
Nephrol Dial Transplant, 23 (12), 4054-60
PubMed 18577532

van Agteren M, Armstrong VW, van Schaik RH, de Fijter H, Hartmann A, Zeier M, Budde K, Kuypers D, Pisarski P, Le Meur Y, van der Werf M, Mamelok RD, Oellerich M, van Gelder T (2008)
AcylMPAG plasma concentrations and mycophenolic acid-related side effects in patients undergoing renal transplantation are not related to the UGT2B7-840G>A gene polymorphism
Ther Drug Monit, 30 (4), 439-44
PubMed 18641546

van Gelder T, Silva HT, de Fijter JW, Budde K, Kuypers D, Tyden G, Lohmus A, Sommerer C, Hartmann A, Le Meur Y, Oellerich M, Holt DW, Tönshoff B, Keown P, Campbell S, Mamelok RD (2008)
Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: the fixed-dose concentration-controlled trial
Transplantation, 86 (8), 1043-51
PubMed 18946341

Witczak BJ, Hartmann A, Geiran OR, Bugge JF (2008)
Renal function after cardiopulmonary bypass surgery in patients with impaired renal function. A randomized study of the effect of nifedipine
Eur J Anaesthesiol, 25 (4), 319-25
PubMed 18182121

Aasebø W, Homb-Vesteraas NA, Hartmann A, Stavem K (2008)
Life situation and quality of life in young adult kidney transplant recipients
Nephrol Dial Transplant, 24 (1), 304-8
PubMed 18840897

Publications 2007

Foss A, Line PD, Brabrand K, Midtvedt K, Hartmann A (2007)
A prospective study on size and function of paediatric kidneys (<10 years) transplanted to adults
Nephrol Dial Transplant, 22 (6), 1738-42
PubMed 17384415

Heldal K, Leivestad T, Hartmann A, Svendsen MV, Lien BH, Midtvedt K (2007)
Kidney transplantation in the elderly--the Norwegian experience
Nephrol Dial Transplant, 23 (3), 1026-31
PubMed 18079146

Hjelmesaeth J, Asberg A, Hartmann A, Jenssen T (2007)
The effect of ciclosporin on insulin secretion and resistance - Reply
Nephrol. Dial. Transplant., 22 (11), 3359

Hjelmesaeth J, Hagen LT, Asberg A, Midtvedt K, Størset O, Halvorsen CE, Mørkrid L, Hartmann A, Jenssen T (2007)
The impact of short-term ciclosporin A treatment on insulin secretion and insulin sensitivity in man
Nephrol Dial Transplant, 22 (6), 1743-9
PubMed 17299003

Hjelmesaeth J, Jenssen T, Hartmann A (2007)
Ghrelin, atherosclerosis, and glucose: GAG or causal relationships?
Transplantation, 84 (10), 1220-1
PubMed 18049105

Sagedal S, Rollag H, Hartmann A (2007)
Cytomegalovirus infection in renal transplant recipients is associated with impaired survival irrespective of expected mortality risk
Clin Transplant, 21 (3), 309-13
PubMed 17488378

Valderhaug TG, Hjelmesaeth J, Rollag H, Leivestad T, Røislien J, Jenssen T, Hartmann A (2007)
Reduced incidence of new-onset posttransplantation diabetes mellitus during the last decade
Transplantation, 84 (9), 1125-30
PubMed 17998867

Voytovich MH, Haukereid C, Hjelmesaeth J, Hartmann A, Løvik A, Jenssen T (2007)
Nateglinide improves postprandial hyperglycemia and insulin secretion in renal transplant recipients
Clin Transplant, 21 (2), 246-51
PubMed 17425753

Witczak BJ, Jenssen T, Endresen K, Røislien J, Hartmann A (2007)
Risk factors for mortality in diabetic nephropathy patients accepted for transplantation
Transplantation, 84 (3), 356-61
PubMed 17700161

Publications 2006

Asberg A, Midtvedt K, Line PD, Narverud J, Holdaas H, Jenssen T, Reisaeter AV, Johnsen LF, Fauchald P, Hartmann A (2006)
Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipients
Transplantation, 82 (1), 62-8
PubMed 16861943

Hartmann A (2006)
[Hypercalcemia and proteinuria]
Tidsskr Nor Laegeforen, 126 (20), 2668
PubMed 17063596

Hartmann A, Holdaas H, Os I, Hunderi OH, Hallan S, Widerøe TE, Svarstad E, Selvig K, Skjønsberg H, Toft I (2006)
[Staging and measurement of renal function in chronic renal conditions]
Tidsskr Nor Laegeforen, 126 (9), 1198-200
PubMed 16670740

Hartmann A, Sagedal S, Hjelmesaeth J (2006)
The natural course of cytomegalovirus infection and disease in renal transplant recipients
Transplantation, 82 (2 Suppl), S15-7
PubMed 16858268

Hjelmesaeth J, Flyvbjerg A, Jenssen T, Frystyk J, Ueland T, Hagen M, Hartmann A (2006)
Hypoadiponectinemia is associated with insulin resistance and glucose intolerance after renal transplantation: impact of immunosuppressive and antihypertensive drug therapy
Clin J Am Soc Nephrol, 1 (3), 575-82
PubMed 17699261

Hjelmesaeth J, Ueland T, Flyvbjerg A, Bollerslev J, Leivestad T, Jenssen T, Hansen TK, Thiel S, Sagedal S, Røislien J, Hartmann A (2006)
Early posttransplant serum osteoprotegerin levels predict long-term (8-year) patient survival and cardiovascular death in renal transplant patients
J Am Soc Nephrol, 17 (6), 1746-54
PubMed 16687626

Mandla R, Midtvedt K, Line PD, Hartmann A, Bergan S (2006)
Mycophenolic acid clinical pharmacokinetics influenced by a cyclosporine C2 based immunosuppressive regimen in renal allograft recipients
Transpl Int, 19 (1), 44-53
PubMed 16359376

Voytovich MH, Asberg A, Hjelmesaeth J, Jenssen T, Hartmann A (2006)
Association between insulin resistance and endothelial dysfunction in renal transplant recipients
Clin Transplant, 20 (2), 195-9
PubMed 16640526

Publications 2005

Hermann M, Asberg A, Christensen H, Reubsaet JL, Holdaas H, Hartmann A (2005)
Atorvastatin does not affect the pharmacokinetics of cyclosporine in renal transplant recipients
Eur J Clin Pharmacol, 61 (1), 59-62
PubMed 15711834

Hjelmesaeth J, Asberg A, Müller F, Hartmann A, Jenssen T (2005)
New-onset posttransplantation diabetes mellitus: insulin resistance or insulinopenia? Impact of immunosuppressive drugs, cytomegalovirus and hepatitis C virus infection
Curr Diabetes Rev, 1 (1), 1-10
PubMed 18220577

Hjelmesaeth J, Müller F, Jenssen T, Rollag H, Sagedal S, Hartmann A (2005)
Is there a link between cytomegalovirus infection and new-onset posttransplantation diabetes mellitus? Potential mechanisms of virus induced beta-cell damage
Nephrol Dial Transplant, 20 (11), 2311-5
PubMed 16046502

Oberbauer R, Segoloni G, Campistol JM, Kreis H, Mota A, Lawen J, Russ G, Grinyó JM, Stallone G, Hartmann A, Pinto JR, Chapman J, Burke JT, Brault Y, Neylan JF, Rapamune Maintenance Regimen Study Group (2005)
Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation
Transpl Int, 18 (1), 22-8
PubMed 15612979

Russ G, Segoloni G, Oberbauer R, Legendre C, Mota A, Eris J, Grinyó JM, Friend P, Lawen J, Hartmann A, Schena FP, Lelong M, Burke JT, Neylan JF, Rapamune Maintenance Regimen Study Group (2005)
Superior outcomes in renal transplantation after early cyclosporine withdrawal and sirolimus maintenance therapy, regardless of baseline renal function
Transplantation, 80 (9), 1204-11
PubMed 16314787

Sagedal S, Hartmann A, Osnes K, Bjørnsen S, Torremocha J, Fauchald P, Kofstad J, Brosstad F (2005)
Intermittent saline flushes during haemodialysis do not alleviate coagulation and clot formation in stable patients receiving reduced doses of dalteparin
Nephrol Dial Transplant, 21 (2), 444-9
PubMed 16234293

Witczak B, Hartmann A, Svennevig JL (2005)
Multiple risk assessment of cardiovascular surgery in chronic renal failure patients
Ann Thorac Surg, 79 (4), 1297-302
PubMed 15797066

Aasebø W, Midtvedt K, Hartmann A, Stavem K (2005)
Predictors of health-related quality of life in hypertensive recipients following renal transplantation
Clin Transplant, 19 (6), 756-62
PubMed 16313321

Publications 2004

Fellström B, Holdaas H, Jardine AG, Holme I, Nyberg G, Fauchald P, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Olsson AG, Hartmann A, Logan JO, Pedersen TR, Assessment of Lescol in Renal Transplantation Study Investigators (2004)
Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial
Kidney Int, 66 (4), 1549-55
PubMed 15458450

Hartmann A, Midtvedt K, Witczak B (2004)
[Kidney injuries and kidney failure caused by drugs]
Tidsskr Nor Laegeforen, 124 (21), 2765-6
PubMed 15534671

Hunderi OH, Hovda KE, Lie B, Listerud S, Hartmann A, Jacobsen D (2004)
[Methanol poisoning in Norway 2002]
Tidsskr Nor Laegeforen, 124 (24), 3199-202
PubMed 15608765

Midtvedt K, Hjelmesaeth J, Hartmann A, Lund K, Paulsen D, Egeland T, Jenssen T (2004)
Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal
J Am Soc Nephrol, 15 (12), 3233-9
PubMed 15579527

Sagedal S, Hartmann A (2004)
Low molecular weight heparins as thromboprophylaxis in patients undergoing hemodialysis/hemofiltration or continuous renal replacement therapies
Eur J Med Res, 9 (3), 125-30
PubMed 15096322

Sagedal S, Hartmann A, Nordal KP, Osnes K, Leivestad T, Foss A, Degré M, Fauchald P, Rollag H (2004)
Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival
Kidney Int, 66 (1), 329-37
PubMed 15200441

Voytovich MH, Simonsen C, Jenssen T, Hjelmesaeth J, Asberg A, Hartmann A (2004)
Short-term treatment with rosiglitazone improves glucose tolerance, insulin sensitivity and endothelial function in renal transplant recipients
Nephrol Dial Transplant, 20 (2), 413-8
PubMed 15615809

Publications 2003

Asberg A, Holdaas H, Jardine AG, Edvardsen C, Hartmann A (2003)
Fluvastatin reduces atherogenic lipids without any effect on native endothelial function early after kidney transplantation
Clin Transplant, 17 (4), 385-90
PubMed 12868997

Hagen M, Hjelmesaeth J, Jenssen T, Morkrid L, Hartmann A (2003)
A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients
Nephrol Dial Transplant, 18 (10), 2154-9
PubMed 13679495

Hartmann A, Fauchald P, Westlie L, Brekke IB, Holdaas H (2003)
The risk of living kidney donation
Nephrol Dial Transplant, 18 (5), 871-3
PubMed 12686656

Hjelmesaeth J, Jenssen T, Hagen M, Egeland T, Hartmann A (2003)
Determinants of insulin secretion after renal transplantation
Metabolism, 52 (5), 573-8
PubMed 12759886

Hjelmesaeth J, Jenssen T, Hartmann A (2003)
Diagnosing PTDM
Transplantation, 75 (10), 1761
PubMed 12777872

Holdaas H, Fellström B, Jardine AG, Holme I, Nyberg G, Fauchald P, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Olsson AG, Hartmann A, Solbu DO, Pedersen TR, Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators (2003)
Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial
Lancet, 361 (9374), 2024-31
PubMed 12814712

Midtvedt K, Fauchald P, Lien B, Hartmann A, Albrechtsen D, Bjerkely BL, Leivestad T, Brekke IB (2003)
Individualized T cell monitored administration of ATG versus OKT3 in steroid-resistant kidney graft rejection
Clin Transplant, 17 (1), 69-74
PubMed 12588325

Sagedal S, Nordal KP, Hartmann A, Midtvedt K, Foss A, Asberg A, Degré M, Fauchald P, Rollag H (2003)
Pre-emptive therapy of CMVpp65 antigen positive renal transplant recipients with oral ganciclovir: a randomized, comparative study
Nephrol Dial Transplant, 18 (9), 1899-908
PubMed 12937241

Westlie L, Leivestad T, Holdaas H, Lien B, Hartmann A, Fauchald P (2003)
[Is current practice concerning living donors in kidney transplantations acceptable?]
Tidsskr Nor Laegeforen, 123 (8), 1063-5
PubMed 12760222

Publications 2002

Hartmann A, Jenssen T, Midtvedt K, Reisaeter AV, Fauchald P, Henriksen T, Monn E, Christophersen B (2002)
[Protein-creatinine ratio--a simple method for proteinuria assessment in clinical practice]
Tidsskr Nor Laegeforen, 122 (22), 2180-3
PubMed 12426892

Hjelmesaeth J, Hagen M, Hartmann A, Midtvedt K, Egeland T, Jenssen T (2002)
The impact of impaired insulin release and insulin resistance on glucose intolerance after renal transplantation
Clin Transplant, 16 (6), 389-96
PubMed 12437616

Hjelmesaeth J, Jenssen T, Egeland T, Hagen M, Hartmann A (2002)
Response to Montori et al. Post-transplantation diabetes (PTD), risk factors for its development, prognostic implications, and optimal management of the disease
Diabetes Care, 25 (9), 1667; discussion 1667-8
PubMed 12196456

Hjelmesaeth J, Jenssen T, Hartmann A (2002)
Diagnosing PTDM
Transplantation, 74 (4), 579
PubMed 12352924

Midtvedt K, Hartmann A (2002)
Hypertension after kidney transplantation: are treatment guidelines emerging?
Nephrol Dial Transplant, 17 (7), 1166-9
PubMed 12105236

Osterby R, Hartmann A, Nyengaard JR, Bangstad HJ (2002)
Development of renal structural lesions in type-1 diabetic patients with microalbuminuria. Observations by light microscopy in 8-year follow-up biopsies
Virchows Arch, 440 (1), 94-101
PubMed 11942582

Sagedal S, Nordal KP, Hartmann A, Sund S, Scott H, Degré M, Foss A, Leivestad T, Osnes K, Fauchald P, Rollag H (2002)
The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients
Am J Transplant, 2 (9), 850-6
PubMed 12392291